CEL-SCI Corporation news

   Watch this stock
Showing stories 41 - 50 of about 87   

Articles published

CVM 1.87 +0.07 (3.89%)
price chart
Mid-Day Market Update: Sorl Auto Parts Drops After Q2 Results; CEL-SCI Shares ...
Shares of CEL-SCI Corporation (NYSE: CVM ) got a boost, shooting up 26 percent to $2.90 as the company disclosed that Phase 3 head & neck cancer trial's clinical hold has been removed by the FDA.
Investor's Alert (RSI Analysis): CEL-SCI Corporation (NYSE: CVM)
On Thursday, Shares of CEL-SCI Corporation (NYSE: CVM) expressed a change of -4.86% and closed its trade at $1.76. The stock exchanged hands with 152,455 numbers of shares compared to its average daily volume of 211.84K shares.
Form 4 CEL SCI CORP For: Oct 02 Filed by: TALOR EYAL
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. TALOR EYAL. (Last), (First), (Middle). 8229 BOONE BLVD. STE 802. (Street). VIENNA, VA, 22182 ...
Cel-Sci says arbitration with inVentiv nearing an end
The arbitration relates to a Phase III trial of Cel-Sci's candidate immunotherapy Multikine (Leukocyte Interleukin, Injection) in the treatment of patients suffering squamous cell carcinoma of the head and neck.
CEL-SCI nabs new European patent covering Multikine; shares rally 41%
Penny stock CEL-SCI (CVM +40.9%) jumps on a 10x surge in volume in response to its announcement that the European Patent Office has granted it a new patent covering lead product candidate Multikine (Leukocyte Interleukin, Injection), an immunotherapy ...
CEL-SCI (CVM) Stock: Soars On Intent To Grant Patent By EU Patent Office  CNA Finance (press release)
Could Cel Sci Corporation (NYSEMKT:CVM) Skyrocket? The Stock Had Too Little ...
The stock of Cel Sci Corporation (NYSEMKT:CVM) registered a decrease of 17.07% in short interest. CVM's total short interest was 628,800 shares in September as published by FINRA.
RBC Capital Maintained Scripps Networks (SNI) As Hold; Has PT Of $90.0; Shorts ...
Cel Sci Corporation (NYSEAMERICAN:CVM) had a decrease of 17.07% in short interest. CVM's SI was 628,800 shares in October as released by FINRA.
Are Discerning Investors Interested in These Shares: CEL-SCI Corporation (:CVM)?
CEL-SCI Corporation (:CVM) are valued at $1.87 at the time of writing and have moved 3.85% since the open. Smart investors often look for value stocks with upside potential.
NIH Awards $1.5M Grant to Help Develop Rheumatoid Arthritis Vaccine
CEL-SCI Corporation announced that it has been awarded a new Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Arthritis and Musculoskeletal and Skin Diseases entitled “Preclinical studies of PG70 LEAPS peptide ...
Stock on the Move: CEL-SCI Corporation (NYSE:CVM)
CEL-SCI Corporation (NYSE:CVM) 12.43% during real-time trade, a total of 2,015,416 shares exchanged hands compared with its average trading volume of 176.57K shares.